Tuberculosis in London: the convergence of clinical and social complexity

Anderson Charlotte, Anderson Sarah R., Maguire Helen, Hayward Andrew C., Story Alistair

Source: Eur Respir J 2016; 48: 1233-1236
Journal Issue: October
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anderson Charlotte, Anderson Sarah R., Maguire Helen, Hayward Andrew C., Story Alistair. Tuberculosis in London: the convergence of clinical and social complexity. Eur Respir J 2016; 48: 1233-1236

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tuberculosis in prisons: anatomy of global neglect
Source: Eur Respir J 2011; 38: 752-754
Year: 2011


Tuberculosis elimination: theory and practice in Europe
Source: Eur Respir J 2014; 43: 1410-1420
Year: 2014



The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe},
Source: Eur Respir J 2012; 40: 806-808
Year: 2012


Tuberculosis lineage in a low prevalence area; epidemiology and clinical characteristics
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013

Tuberculosis: clinical scenario
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Paediatric respiratory training in Europe: political, educational and historical perspective
Source: Breathe 2009; 5: 374-383
Year: 2009

Childhood tuberculosis outbreaks in EU/EEA: A systematic review
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Tuberculosis in Bucharest continues to be a concern
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Tuberculosis elimination in Oman: winning the war on the disease
Source: ERJ Open Res, 4 (4) 00121-2018; 10.1183/23120541.00121-2018
Year: 2018



Latent TB in healthcare workers from high prevalence countries at city hospital Sunderland foundation trust (CHSFT); epidemiology and management
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Research emphysis in China: big data network for respiratory health
Source: International Congress 2019 – Chinese programme 2019: Part I
Year: 2019


Management of tuberculosis (TB) at a district general hospital: An audit of practice
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Research in Europe: from basic science to interdisciplinary approach
Source: Annual Congress 2013 –President Summit 2013 update: Research gaps, patient needs & innovative solutions: a forward look on lung health research
Year: 2013


European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?
Source: Eur Respir J 2016; 48: 1564-1568
Year: 2016


Evaluation of the accuracy of tuberculosis surveillance system by comparison with medical record in Korea
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016